These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 2070501)
21. Carcinogenicity of butylated hydroxyanisole in F344 rats. Ito N; Fukushima S; Hagiwara A; Shibata M; Ogiso T J Natl Cancer Inst; 1983 Feb; 70(2):343-52. PubMed ID: 6571941 [TBL] [Abstract][Full Text] [Related]
22. Carcinogenicity and modification of the carcinogenic response by BHA, BHT, and other antioxidants. Ito N; Fukushima S; Tsuda H Crit Rev Toxicol; 1985; 15(2):109-50. PubMed ID: 3899519 [TBL] [Abstract][Full Text] [Related]
23. Short-term pathological and proliferative effects of butylated hydroxyanisole and other phenolic antioxidants in the forestomach of Fischer 344 rats. Nera EA; Lok E; Iverson F; Ormsby E; Karpinski KF; Clayson DB Toxicology; 1984 Sep; 32(3):197-213. PubMed ID: 6474484 [TBL] [Abstract][Full Text] [Related]
24. Dose-response study on covalent binding to forestomach protein from male F344 rats following oral administration of [14C]3-BHA. Morimoto K; Takahashi T; Okudaira K; Iio T; Saito Y; Takahashi A Carcinogenesis; 1992 Sep; 13(9):1663-6. PubMed ID: 1394853 [TBL] [Abstract][Full Text] [Related]
25. Induction of cell proliferation in the forestomach of F344 rats following subchronic administration of styrene 7,8-oxide and butylated hydroxyanisole. Cantoreggi S; Dietrich DR; Lutz WK Cancer Res; 1993 Aug; 53(15):3505-8. PubMed ID: 8339254 [TBL] [Abstract][Full Text] [Related]
26. Enhancing effect of concomitant L-ascorbic acid administration on BHA-induced forestomach carcinogenesis in rats. Shibata MA; Hirose M; Kagawa M; Boonyaphiphat P; Ito N Carcinogenesis; 1993 Feb; 14(2):275-80. PubMed ID: 8435867 [TBL] [Abstract][Full Text] [Related]
27. Mutagenicity of 3-tert-butyl-4-hydroxyanisole (BHA) and its metabolites in short-term tests in vitro. Matsuoka A; Matsui M; Miyata N; Sofuni T; Ishidate M Mutat Res; 1990 Jun; 241(2):125-32. PubMed ID: 2345551 [TBL] [Abstract][Full Text] [Related]
28. Effects of hydroquinone-type and phenolic antioxidants on calcium signals and degranulation of RBL-2H3 cells. Akasaka R; Teshima R; Kitajima S; Momma J; Inoue T; Kurokawa Y; Ikebuchi H; Sawada J Biochem Pharmacol; 1996 Jun; 51(11):1513-9. PubMed ID: 8630092 [TBL] [Abstract][Full Text] [Related]
29. Induction of oxidative DNA damage and early lesions in rat gastro-intestinal epithelium in relation to prostaglandin H synthase-mediated metabolism of butylated hydroxyanisole. Schilderman PA; ten Vaarwerk FJ; Lutgerink JT; Van der Wurff A; ten Hoor F; Kleinjans JC Food Chem Toxicol; 1995 Feb; 33(2):99-109. PubMed ID: 7868004 [TBL] [Abstract][Full Text] [Related]
30. Modification of BHA forestomach carcinogenesis in rats: inhibition by diethylmaleate or indomethacin and enhancement by a retinoid. Shibata MA; Hirose M; Masuda A; Kato T; Mutai M; Ito N Carcinogenesis; 1993 Jul; 14(7):1265-9. PubMed ID: 8330338 [TBL] [Abstract][Full Text] [Related]
31. Modifying effects of simultaneous treatment with butylated hydroxyanisole (BHA) on rat tumor induction by 3,2'-dimethyl-4-aminobiphenyl, 2,2'-dihydroxy-di-n-propylnitrosamine and N-methylnitrosourea. Ito N; Hirose M; Shibata M; Tanaka H; Shirai T Carcinogenesis; 1989 Dec; 10(12):2255-9. PubMed ID: 2591015 [TBL] [Abstract][Full Text] [Related]
32. Metabolism of 2- and 3-tert-butyl-4-hydroxyanisole (2- and 3-BHA) in the rat. (II): Metabolism in forestomach and covalent binding to tissue macromolecules. Hirose M; Asamoto M; Hagiwara A; Ito N; Kaneko H; Saito K; Takamatsu Y; Yoshitake A; Miyamoto J Toxicology; 1987 Jul; 45(1):13-24. PubMed ID: 3603573 [TBL] [Abstract][Full Text] [Related]
33. Effects of butylated hydroxyanisole pretreatment on low dose N-methyl-N'-nitro-N-nitrosoguanidine- or N,N-dibutylnitrosamine-induced rat forestomach or esophageal carcinogenesis. Hirose M; Uwagawa S; Ozaki K; Takaba K; Ito N Carcinogenesis; 1991 Oct; 12(10):1773-6. PubMed ID: 1934256 [TBL] [Abstract][Full Text] [Related]
34. Butylated hydroxyanisole (BHA) does not cause forestomach hyperplasia by inhibiting the release of gastric mucus. Lauriault V; Grasso P; Powell CJ Toxicology; 1990 Dec; 64(3):281-90. PubMed ID: 2125152 [TBL] [Abstract][Full Text] [Related]
36. The carcinogenic effect of butylated hydroxyanisole on the stratified epithelium of the stomach in rat versus pig. Olsen P Cancer Lett; 1983 Nov; 21(1):115-6. PubMed ID: 6640510 [TBL] [Abstract][Full Text] [Related]
37. Antagonistic effect of diethylmaleate on the promotion of forestomach carcinogenesis by butylated hydroxyanisole (BHA) in rats pretreated with N-methyl-N'-nitro-N-nitrosoguanidine. Hirose M; Kagawa M; Ogawa K; Yamamoto A; Ito N Carcinogenesis; 1989 Dec; 10(12):2223-6. PubMed ID: 2591011 [TBL] [Abstract][Full Text] [Related]
38. Inhibition by 2(3)-tert-butyl-4-hydroxyanisole and other antioxidants of epidermal ornithine decarboxylase activity induced by 12-O-tetradecanoylphorbol-13-acetate. Kozumbo WJ; Seed JL; Kensler TW Cancer Res; 1983 Jun; 43(6):2555-9. PubMed ID: 6850576 [TBL] [Abstract][Full Text] [Related]
39. Disappearance of upward proliferation and persistence of downward basal cell proliferation in rat forestomach papillomas induced by butylated hydroxyanisole. Masui T; Asamoto M; Hirose M; Fukushima S; Ito N Jpn J Cancer Res; 1986 Sep; 77(9):854-7. PubMed ID: 3095280 [TBL] [Abstract][Full Text] [Related]
40. DNA damage in forestomach epithelium from male F344 rats following oral administration of tert-butylquinone, one of the forestomach metabolites of 3-BHA. Morimoto K; Tsuji K; Iio T; Miyata N; Uchida A; Osawa R; Kitsutaka H; Takahashi A Carcinogenesis; 1991 Apr; 12(4):703-8. PubMed ID: 2013134 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]